Last reviewed · How we verify

NCT07113704

Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Safe Alternative Technique

Completed Last updated 11 August 2025
What this trial tests

trial testing Conventional Laparoscopic Cholecystectomy in Cholelithiasis in 124 participants. Completed in 10 April 2024.

Timeline
5 January 2023
Primary endpoint
1 April 2024
10 April 2024

Quick facts

Lead sponsorKANAN ISMAYILZADA, MD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment124
Start date5 January 2023
Primary completion1 April 2024
Estimated completion10 April 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

KANAN ISMAYILZADA, MD

Who can join

18 and older, any sex, with Cholelithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective cross-sectional study evaluated the safety and effectiveness of the fundus-first laparoscopic cholecystectomy (FFLC) technique in patients with difficult gallbladders. A total of 124 patients who underwent FFLC between 2023 and 2024 were reviewed. The study assessed operative time, intraoperative complications, conversion rates, and postoperative outcomes. The results suggest that FFLC is a safe and feasible approach that can reduce the need for conversion to open surgery in complex cases. The study was conducted at a private hospital in Istanbul, Turkey

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Conventional Laparoscopic Cholecystectomy

Trials testing the same drug.

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07113704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing